Vir Biotechnology (VIR) Gross Profit (2020 - 2026)
Vir Biotechnology (VIR) posted Gross Profit of $1.2 million for Q2 2025, down 60.32% sequentially from $3.0 million in Q1 2025, and down 60.21% YoY from $3.0 million in Q2 2024.
Vir Biotechnology (VIR) Gross Profit (2020 - 2026) Analysis & Trends
Vir Biotechnology has reported Gross Profit for 6 years, with the latest figure at $1.2 million in Q2 2025.
- Quarterly Gross Profit fell 60.21% year-over-year to $1.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $18.3 million (down 75.08% YoY) and the FY2025 annual result came in at $68.5 million, down 6.58% from the prior year.
- Gross Profit eased to $1.2 million in Q2 2025 per VIR's latest filing, from $3.0 million in the prior quarter.
- Over five years, Gross Profit peaked at $1.1 billion in Q1 2022 and troughed at $1.2 million in Q2 2025.
- A 5-year average of $151.5 million and a median of $14.3 million in 2022 frame the typical range for Gross Profit.
- The sharpest annual moves came in 2022 and 2023: Gross Profit jumped 57709.21% in 2022, then sank 99.26% in 2023.
- Over 5 years, Gross Profit stood at $755.9 million in 2021, then sank by 94.26% to $43.4 million in 2022, then plunged by 63.17% to $16.0 million in 2023, then dropped by 26.89% to $11.7 million in 2024, then sank by 89.71% to $1.2 million in 2025.
- According to Business Quant data, Gross Profit over the past three periods registered $1.2 million, $3.0 million, and $11.7 million for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Vir Biotechnology | 1.56 Bn | 1.56 Bn | 238.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 238.95 Mn |
| Jun 30, 2026 | 238.95 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 11.69 Mn |
| Dec 31, 2024 | 11.69 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 3.02 Mn |
| Jun 30, 2024 | 3.02 Mn |
| Mar 31, 2024 | 51.64 Mn |
| Mar 31, 2024 | 51.64 Mn |
| Dec 31, 2023 | 15.99 Mn |
| Dec 31, 2023 | 15.99 Mn |
| Sep 30, 2023 | 2.60 Mn |
| Sep 30, 2023 | 2.60 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Jun 30, 2023 | 3.78 Mn |